Immune Therapeutics, Inc. 5
5 · Immune Therapeutics, Inc. · Filed Feb 17, 2015
Insider Transaction Report
Form 5
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
COMMON STOCK
2014-06-16+0→ 2,685,000 total(indirect: By Trust)
Footnotes (1)
- [F1]The total number of shares has been adjusted to reflect shares inadvertently not included in previous reports. These shares are held in an irrevocable trust for the benefit of the reporting person's children and grandchildren. The reporting person's sister-in-law is trustee of the trust.